Tag: OPDP enforcement

CHC-offLabel2

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

CHC_DTCadvertisement2

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

socialmedia.news (1)

OPDP Cites Lilly for Omission of Risk Info in Trulicity Instagram Post

CHC_DTCadvertisement2

OPDP, Lilly Come to Terms Over TV Ads for Migraine Drug

FDA-News (1)

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

fda-logo

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery

NewsRadio

Addyi Radio Ad Garners OPDP Warning Letter for Omission of Risks

CHC_DTCadvertisement2

OPDP Cites Xeris for Risk Presentation Issues in DTC TV Ad

FDA-News (1)

By One Measure, 2020 OPDP Enforcement Is Off to Slow Start